Arcellx

Arcellx is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.

Business Model:

Revenue: $0

Employees: 51-200

Detailed Arcellx Information

Geographic Data

Arcellx headquarters map

Address: 25 West Watkins Mill Road

City: Gaithersburg

State: MD

Zip: 20878

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$112M

Raised Total:

$207M

Metrics

1,692,246Website Global Rank

13,876Website Monthly Traffic

Twitter Followers

Description

Arcellx is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.

Contact Phone:
+12403270603

Contact Email:

Arcellx went public on 2/4/2022 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/4/2022

IPO Valuation:
$503M

Ticker Symbol:
ACLX

IPO Price:
$15/share

Amount Raised:
$124M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2023 Post-IPO Equity $100M New Enterprise Associates
SR One
Solasta Ventures
4/2021 Series C - CaaS Capital Management
Adage Capital Management
CAM Capital
Asymmetry Ventures
LG Technology Ventures
Cambrian Biopharma
Clough Capital Partners
CAM Capital
CaaS Capital Management
Adage Capital Management
CAM Capital
Asymmetry Ventures
LG Technology Ventures
Cambrian Biopharma
Clough Capital Partners
CAM Capital
6/2022 Post-IPO Equity $128.8M
3/2021 Series C $120M Samsara BioCapital
CAM Capital
Asymmetry
CaaS Capital
Cambrian Bio
Sixty Degree
Soleus Capital
Surveyor Capital
Terra Magnum Capital Partners
NEA
Novo Holdings
S.R. One Limited
Takeda Ventures
LG Technology Ventures
Clough Capital Partners, L.P
2/2022 Post-IPO Equity $10M New Enterprise Associates
SR One Capital Management, LP
Quan Capital
Solasta Ventures
2/2022 IPO $123.8M
12/2022 Post-IPO Equity 1 $100M Kite Pharma
Kite Pharma
3/2022 Post-IPO Equity $10M
10/2019 Series B $0 LG Technology Ventures
JVC Investment Partners
Solasta Ventures
Aju IB Investment
Quan Capital
Clough Capital Partners
Mirae Asset Capital
Mirae Asset Venture Investment
New Enterprise Associates
Novo Holdings
SR One
Takeda Ventures
LG Technology Ventures
JVC Investment Partners
Solasta Ventures
Aju IB Investment
Quan Capital
Clough Capital Partners
Mirae Asset Capital
Mirae Asset Venture Investment
New Enterprise Associates
Novo Holdings
SR One
Takeda Ventures
6/2022 Post-IPO Equity $112M
9/2017 Series A 1 - Novo Ventures
Novo Ventures
4/2021 Series C 7 - CaaS Capital Management
Adage Capital Management
CAM Capital
Asymmetry Ventures
LG Technology Ventures
Cambrian Biopharma
Clough Capital Partners
CAM Capital
CaaS Capital Management
Adage Capital Management
CAM Capital
Asymmetry Ventures
LG Technology Ventures
Cambrian Biopharma
Clough Capital Partners
CAM Capital
10/2019 Series B 12 $85M LG Technology Ventures
JVC Investment Partners
Solasta Ventures
Aju IB Investment
Quan Capital
LG Technology Ventures
JVC Investment Partners
Solasta Ventures
Aju IB Investment
Quan Capital
9/2017 Series A 1 -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research